Order Article Reprints

Cirillo A, Zizzari IG, Botticelli A, Strigari L, Rahimi H, Scagnoli S, Scirocchi F, Pernazza A, Pace A, Cerbelli B, et al. Circulating CD137⁺ T Cell Levels Are Correlated with Response to Pembrolizumab Treatment in Advanced Head and Neck Cancer Patients. International Journal of Molecular Sciences. 2023; 24(8):7114. https://doi.org/10.3390/ijms24087114

Cirillo, Alessio, Ilaria Grazia Zizzari, Andrea Botticelli, Lidia Strigari, Hassan Rahimi, Simone Scagnoli, Fabio Scirocchi, Angelina Pernazza, Angelica Pace, Bruna Cerbelli, and et al. 2023. "Circulating CD137⁺ T Cell Levels Are Correlated with Response to Pembrolizumab Treatment in Advanced Head and Neck Cancer Patients" International Journal of Molecular Sciences 24, no. 8: 7114. https://doi.org/10.3390/ijms24087114

Cirillo, A., Zizzari, I. G., Botticelli, A., Strigari, L., Rahimi, H., Scagnoli, S., Scirocchi, F., Pernazza, A., Pace, A., Cerbelli, B., d’Amati, G., Marchetti, P., Nuti, M., Rughetti, A., & Napoletano, C. (2023). Circulating CD137⁺ T Cell Levels Are Correlated with Response to Pembrolizumab Treatment in Advanced Head and Neck Cancer Patients. International Journal of Molecular Sciences, 24(8), 7114. https://doi.org/10.3390/ijms24087114